Pasithea Therapeutics Cor... (KTTA)

1.13

-0.03 (-2.59%)

At close: Mar 03, 2025, 3:59 PM

1.07

-4.89%

After-hours: Mar 03, 2025, 06:59 PM EST

Pasithea Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20
Net Income	-15.51M	-13.94M	-2.17M	-40.98K
Depreciation & Amortization	648.45K	32.37K	1.38K	n/a
Stock-Based Compensation	592.27K	835.06K	471.25K	n/a
Other Working Capital	1.57M	-831.78M	-329.44K	2.29K
Other Non-Cash Items	-732.57K	-1.07M	750K	9.9K
Deferred Income Tax	n/a	n/a	-2.33M	n/a
Change in Working Capital	1.57M	-138.44K	111.23K	2.29K
Operating Cash Flow	-13.43M	-14.56M	-3.17M	-38.69K
Capital Expenditures	-34.3K	-2.14M	-21.5K	n/a
Acquisitions	n/a	77.06K	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a
Other Investing Acitivies	433.31K	-626.9K	n/a	n/a
Investing Cash Flow	399.01K	-2.06M	-21.5K	n/a
Debt Repayment	n/a	n/a	n/a	n/a
Common Stock Repurchased	-3.73M	-3.21M	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	-3.21K	5.69M	282.34K
Financial Cash Flow	-3.73M	-3.21M	55.93M	282.34K
Net Cash Flow	-16.76M	-19.82M	52.72M	243.65K
Free Cash Flow	-12.85M	-16.7M	-3.2M	-38.69K